Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash $ 10,891,736 $ 9,601,298
Prepaid expenses and other current assets 780,515 473,834
Australia research and development incentives receivable 82,685 77,347
Total current assets 11,754,936 10,152,479
Other assets 27,085 2,800
Total assets 11,782,021 10,155,279
Current liabilities:    
Accounts payable 3,175,641 1,512,436
Accrued expenses 6,818,803 2,317,602
Total current liabilities 9,994,444 3,830,038
Long term liabilities:    
Warrant liability 1,745,907 2,690,605
Total liabilities 11,740,351 6,520,643
Commitments and contingencies (Note 7)
Stockholders’ equity (deficit)    
Preferred stock, $0.0001 par value, 30,000,000 shares authorized at September 30, 2025 and December 31, 2024, 0 shares issued and outstanding
Common stock, $0.0001 par value, 150,000,000 shares and 70,000,000 shares authorized at September 30, 2025 and at December 31, 2024, respectively, 34,451,153 and 26,157,788 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 3,446 2,616
Additional paid-in capital 106,071,303 90,897,468
Accumulated deficit (106,002,244) (87,234,833)
Accumulated other comprehensive loss (30,835) (30,615)
Total stockholders’ equity 41,670 3,634,636
Total liabilities and stockholders’ equity $ 11,782,021 $ 10,155,279